UK anticoagulants market is estimated to grow at a CAGR of 7.0% during the forecast period. Rising incidences of CVD have been witnessed in the country which is contributing to the growth of the market. As per the British Heart Federation (BHF), in 2018, nearly 7.4 million people suffering from heart and circulatory diseases in the UK. The growing aging population and sedentary lifestyle habits have resulted in the rising incidences of heart and circulatory diseases in the country. This, in turn, is resulting in an increasing demand for anticoagulants that are used to prevent the blood from clotting as rapidly or as potentially as normal. Anticoagulants are also known as blood thinners. These medications are used for the treatment and prevention of blood clots that may occur in the blood vessels.
Get Free Sample link @ https://www.omrglobal.com/request-sample/uk-anticoagulants-market
The market is segmented based on type and application. Based on type, the market is classified into novel oral anticoagulants (NOACs), vitamin k antagonist, and heparin, and low molecular weight heparin (LMWH). Based on application, the market is classified into a pulmonary embolism, atrial fibrillation/myocardial infarction (heart attack), deep vein thrombosis, and others. As per the BHF, atrial fibrillation is a major cause of stroke and one of the most common forms of abnormal heart rhythm (arrhythmia). In 2018, nearly 1.4 million people in the country have been diagnosed with atrial fibrillation. This is driving the adoption of anticoagulants that are utilized for the prevention of blood clots and atrial fibrillation (AF) is the most common condition in which blood clots are formed. Therefore, warfarin is used as the most commonly utilized vitamin K antagonist (VKA) to reduce the risk of stroke in certain AF patients with risk factors.
A full report of UK Anticoagulants Market available @ https://www.omrglobal.com/industry-reports/uk-anticoagulants-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
UK Anticoagulants Market by Type
- Novel Oral Anticoagulants (NOACs)
- Vitamin K Antagonist
- Heparin and Low Molecular Weight Heparin (LMWH)
UK Anticoagulants Market by Application
- Pulmonary Embolism
- Atrial Fibrillation/Myocardial Infarction (Heart Attack)
- Deep Vein Thrombosis (DVT)
- Others
Company Profiles
- AstraZeneca plc
- Overview
- Product Portfolio
- Recent Activities
- Abbott Laboratories
- Bayer AG
- Boehringer Ingelheim GmbH
- Bristol Myers Squibb Co.
- Daiichi Sankyo Company, Ltd.
- GlaxoSmithKline plc
- Novartis International AG
- Pfizer Inc.
- Sanofi S.A.
The Report Covers
- Comprehensive research methodology of the UK anticoagulants market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the UK anticoagulants market.
- Insights about market determinants that are stimulating the UK anticoagulants market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/uk-anticoagulants-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
